AN UNBIASED VIEW OF FCCP

Pregnancy is a recognized secondary reason for dyslipidemia, leading to a potential boost in triglyceride and LDL-C concentrations. Statin therapy is contraindicated throughout pregnancy causing limited options for dyslipidemia therapy during pregnancy. Option remedy possibilities are important to treat elevated concentrations throughout pregnancy